Combo vaccine less effective than mono version
Key points
- A vaccine aimed at preventing both pneumococcal disease and meningitis elicits a lower immune response against the meningitis bug than does the single component vaccine, results of a clinical trial show.
- Buttery and colleagues report their findings in this week's Journal of the American Medical Association.
- Buttery, at the University of Melbourne in Parkville, Australia, and his team compared a group C meningococcal vaccine (MenC) against a candidate combination pneumococcal-and-meningococcal vaccine dubbed Pnc9-MenC.
- In each group, 120 infants were given three doses of vaccine at ages 2, 3, and 4 months along with routine childhood inoculations.
A vaccine aimed at preventing both pneumococcal disease and meningitis elicits a lower immune response against the meningitis bug than does the single component vaccine, results of a clinical trial show.
Dr. Jim P. Buttery and colleagues report their findings in this week's Journal of the American Medical Association.
Buttery, at the University of Melbourne in Parkville, Australia, and his team compared a group C meningococcal vaccine (MenC) against a candidate combination pneumococcal-and-meningococcal vaccine dubbed Pnc9-MenC.
In each group, 120 infants were given three doses of vaccine at ages 2, 3, and 4 months along with routine childhood inoculations.
When the infants were tested at age 5 months, levels of antibodies against the meningitis organism were four times greater in the MenC group than the Pcn9-MenC group. The proportion of infants in each group with adequate antibody levels was 94 percent versus 81 percent, respectively.
This study "illustrates the unpredictability of immunogenicity when combining multivalent vaccines," Buttery's group points out.
The Pcn9-MenC vaccine tested "may not be a suitable replacement" for individual MenC or pneumococcal vaccines, they conclude.
SOURCE: Journal of the American Medical Association, April 13, 2005.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsNew technique brings us closer to HIV and hepatitis C vaccines
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking…
26 March 2014
NewsStudy of antibody evolution charts course toward HIV vaccine
In an advance for HIV vaccine research, a scientific team has discovered how the immune system makes a powerful antibody that blocks HIV infection of cells by targeting a site on the virus called V1V2. Many researchers…
3 March 2014
NewsDurable end to AIDS will require HIV vaccine development
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least…
6 February 2014
